{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:32:00Z","timestamp":1707525120184},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,20]]},"DOI":"10.7759\/cureus.40702","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:02:33Z","timestamp":1687305753000},"source":"Crossref","is-referenced-by-count":0,"title":["Potential Ketoacidosis Linked to Imeglimin and Metformin Co-administration in a Patient With Type 2 Diabetes"],"prefix":"10.7759","author":[{"given":"Hirofumi","family":"Yamagishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachina","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taihei","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.21636","article-title":"A review of phenformin, metformin, and imeglimin","volume":"81","author":"Yendapally R","year":"2020","unstructured":"Yendapally R, Sikazwe D, Kim SS, Ramsinghani S, Fraser-Spears R, Witte AP, La-Viola B. A review of phenformin, metformin, and imeglimin. Drug Dev Res. 2020, 81:390-401. 10.1002\/ddr.21636","journal-title":"Drug Dev Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.211","article-title":"The mechanism by which imeglimin inhibits gluconeogenesis in rat liver cells","volume":"4","author":"Vial G","year":"2021","unstructured":"Vial G, Lamarche F, Cottet-Rousselle C, Hallakou-Bozec S, Borel AL, Fontaine E. The mechanism by which imeglimin inhibits gluconeogenesis in rat liver cells. Endocrinol Diabetes Metab. 2021, 4:e00211. 10.1002\/edm2.211","journal-title":"Endocrinol Diabetes Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena G","year":"2017","unstructured":"Rena G, Hardie DG, Pearson ER. The mechanisms of action of metformin. Diabetologia. 2017, 60:1577-85. 10.1007\/s00125-017-4342-z","journal-title":"Diabetologia"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12452","article-title":"Imeglimin increases glucose-dependent insulin secretion and improves \u03b2-cell function in patients with type 2 diabetes","volume":"17","author":"Pacini G","year":"2015","unstructured":"Pacini G, Mari A, Fouqueray P, Bolze S, Roden M. Imeglimin increases glucose-dependent insulin secretion and improves \u03b2-cell function in patients with type 2 diabetes. Diabetes Obes Metab. 2015, 17:541-5. 10.1111\/dom.12452","journal-title":"Diabetes Obes Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14613","article-title":"Long-term safety and efficacy of imeglimin as monotherapy or in combination with existing antidiabetic agents in Japanese patients with type 2 diabetes (TIMES 2): a 52-week, open-label, multicentre phase 3 trial","volume":"24","author":"Dubourg J","year":"2022","unstructured":"Dubourg J, Fouqueray P, Quinslot D, Grouin JM, Kaku K. Long-term safety and efficacy of imeglimin as monotherapy or in combination with existing antidiabetic agents in Japanese patients with type 2 diabetes (TIMES 2): a 52-week, open-label, multicentre phase 3 trial. Diabetes Obes Metab. 2022, 24:609-19. 10.1111\/dom.14613","journal-title":"Diabetes Obes Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0453","article-title":"The efficacy and safety of imeglimin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy","volume":"36","author":"Fouqueray P","year":"2013","unstructured":"Fouqueray P, Pirags V, Inzucchi SE, Bailey CJ, Schernthaner G, Diamant M, Lebovitz HE. The efficacy and safety of imeglimin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy. Diabetes Care. 2013, 36:565-8. 10.2337\/dc12-0453","journal-title":"Diabetes Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2011.03246.x","article-title":"Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis","volume":"28","author":"Savage MW","year":"2011","unstructured":"Savage MW, Dhatariya KK, Kilvert A, et al.. Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis. Diabet Med. 2011, 28:508-15. 10.1111\/j.1464-5491.2011.03246.x","journal-title":"Diabet Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-9032","article-title":"Hyperglycemic crises in adult patients with diabetes","volume":"32","author":"Kitabchi AE","year":"2009","unstructured":"Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009, 32:1335-43. 10.2337\/dc09-9032","journal-title":"Diabetes Care"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200002033420501","article-title":"A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group","volume":"342","author":"Imagawa A","year":"2000","unstructured":"Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N Engl J Med. 2000, 342:301-7. 10.1056\/NEJM200002033420501","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7368","article-title":"A rare case of severe starvation-induced ketoacidosis in a patient with recurrent pancreatitis","volume":"12","author":"Chan KH","year":"2020","unstructured":"Chan KH, Ramahi A. A rare case of severe starvation-induced ketoacidosis in a patient with recurrent pancreatitis. Cureus. 2020, 12:e7368. 10.7759\/cureus.7368","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107584","article-title":"Ketone-body production and oxidation in fasting obese humans","volume":"53","author":"Reichard GA Jr","year":"1974","unstructured":"Reichard GA Jr, Owen OE, Haff AC, Paul P, Bortz WM. Ketone-body production and oxidation in fasting obese humans. J Clin Invest. 1974, 53:508-15. 10.1172\/JCI107584","journal-title":"J Clin Invest"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0165-1","article-title":"Diabetic ketoacidosis","volume":"6","author":"Dhatariya KK","year":"2020","unstructured":"Dhatariya KK, Glaser NS, Codner E, Umpierrez GE. Diabetic ketoacidosis. Nat Rev Dis Primers. 2020, 6:40. 10.1038\/s41572-020-0165-1","journal-title":"Nat Rev Dis Primers"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-0843","article-title":"Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition","volume":"38","author":"Peters AL","year":"2015","unstructured":"Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care. 2015, 38:1687-93. 10.2337\/dc15-0843","journal-title":"Diabetes Care"},{"key":"ref14","article-title":"Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state","volume":"168","author":"Chiasson JL","year":"2003","unstructured":"Chiasson JL, Aris-Jilwan N, B\u00e9langer R, et al.. Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state. CMAJ. 2003, 168:859-66.","journal-title":"CMAJ"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f3501","article-title":"Diabetic ketoacidosis: not always due to type 1 diabetes","volume":"346","author":"Misra S","year":"2013","unstructured":"Misra S, Oliver N, Dornhorst A. Diabetic ketoacidosis: not always due to type 1 diabetes. BMJ. 2013, 346:f3501. 10.1136\/bmj.f3501","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/emj.2004.017590","article-title":"Alcoholic ketoacidosis","volume":"23","author":"McGuire LC","year":"2006","unstructured":"McGuire LC, Cruickshank AM, Munro PT. Alcoholic ketoacidosis. Emerg Med J. 2006, 23:417-20. 10.1136\/emj.2004.017590","journal-title":"Emerg Med J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ams2.13","article-title":"Alcoholic ketoacidosis that developed with a hypoglycemic attack after eating a high-fat meal","volume":"1","author":"Suzuki K","year":"2014","unstructured":"Suzuki K, Tamai Y, Urade S, Ino K, Sugawara Y, Katayama N, Hoshino T. Alcoholic ketoacidosis that developed with a hypoglycemic attack after eating a high-fat meal. Acute Med Surg. 2014, 1:109-14. 10.1002\/ams2.13","journal-title":"Acute Med Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/158469-potential-ketoacidosis-linked-to-imeglimin-and-metformin-co-administration-in-a-patient-with-type-2-diabetes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:04:57Z","timestamp":1707509097000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/158469-potential-ketoacidosis-linked-to-imeglimin-and-metformin-co-administration-in-a-patient-with-type-2-diabetes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,20]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.40702","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,20]]}}}